WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Times gone in a snapPorts across China to see 1.8 mln daily entries, exits during Spring Festival holidayA drink heritage to cherishChina to join Cobra Gold 2024 military exercise in ThailandExhibiting a timeless eleganceXi's Speech at the 30th APEC Economic Leaders' Meeting PublishedXi's Speech at Welcome Dinner by U.S. Friendly Organizations PublishedChina's AG600M firefighting aircraft completes coldChinese swimming team breaks record in mixed 4x100m freestyle relay final in DohaXi sends reply letter to Butuka Academy of Papua New Guinea